Home Weisi Medical Appoints Wang Zhiyu as Chairman; Reports Q3 Net Profit of RMB 38.39 Million and Submits Prospectus

Weisi Medical Appoints Wang Zhiyu as Chairman; Reports Q3 Net Profit of RMB 38.39 Million and Submits Prospectus

Nov 12, 2021 22:20 CST Updated 22:20
VISHEE

Developer, Manufacturer, and Distributor of Rehabilitation Medical Devices

This article is sourced from: Waibei Network

Waibei Network, November 12 — VISHEE (688580) held its second extraordinary shareholders' meeting and staff congress of 2021 on November 12, 2021. The meetings respectively elected the directors of the third board of directors, the non-staff representative supervisors of the third board of supervisors, and the staff representative supervisors of the third board of supervisors. Together, they formed the company’s third board of directors and third board of supervisors, with a term of three years starting from the date of approval at the second extraordinary shareholders' meeting of 2021.

On the same day, the company held the first meeting of the Third Board of Directors and the first meeting of the Third Supervisory Board, respectively reviewing and approving the following proposals: "Proposal on Electing the Chairman of the Third Board of Directors," "Proposal on Electing Members of Each Special Committee of the Third Board of Directors," "Proposal on Appointing the General Manager of the Company," "Proposal on Appointing Other Senior Executives of the Company," "Proposal on Appointing the Securities Affairs Representative of the Company," and "Proposal on Electing the Chairperson of the Third Supervisory Board." The specific details are hereby announced as follows:

Election of the Chairman of the Third Board of Directors: The members of the third board of directors have been elected at the second extraordinary shareholders' meeting of 2021. According to the relevant provisions of the "Company Law of the People's Republic of China" and the "Articles of Association of the Company," the board of directors has elected Wang Zhiyu as the chairman of the third board of directors. The term of office will commence from the date of approval by this board of directors until the expiration of the term of the third board of directors.

Election of Members for Each Special Committee of the Third Board of Directors of the Company:

The members of the third session of the board of directors of the company have been elected at the second extraordinary shareholders' meeting of 2021. According to the "Company Law", "Articles of Association of the Company" and the implementation rules of various special committees of the company, the board of directors of the company intends to elect the members and chairman (convener) of each special committee of the third session of the board of directors as follows:

Audit Committee: Cai Weihua, Xiao Junfang, Chen Lili, with Cai Weihua as the Chairperson (Convener).

Strategic Committee: Wang Zhiyu, He Yimin, Xu Jinguo, with Wang Zhiyu as the Chairman (Convener).

Nomination Committee: He Yimin, Xiao Junfang, Wang Zhiyu, with He Yimin as the Chairman (Convener).

Remuneration and Assessment Committee: Xiao Junfang, Cai Weihua, Li Xiaoming, with Xiao Junfang as the Chairman (Convener).

The term of office for the members of each special committee shall commence from the date of approval by this board of directors and end on the expiration of the term of the third board of directors.

Election of the Chairman of the Third Supervisory Committee of the Company: The members of the Third Supervisory Committee of the Company have been elected at the Second Extraordinary General Meeting of Shareholders in 2021 and the company’s employee representative conference. According to the relevant provisions of the "Company Law" and the "Articles of Association of the Company," the company's supervisory committee has elected Hu Ping as the chairman of the Third Supervisory Committee. The term of office will commence from the date of approval by this supervisory committee meeting until the expiration of the term of the Third Supervisory Committee.

Appointment of Senior Management Personnel: The Board of Directors of the Company has agreed to appoint Wang Zhiyu as the General Manager, Zhong Yiqun, Wu Xia, and Xu Jinguo as Deputy General Managers, Huang He as the Chief Rotating Technology Officer, Zhang Hui as the Chief Operating Officer, Qiu Kai as the Senior R&D Director, Zhong Yiqun as the Secretary of the Board of Directors, and Chen Lili as the Financial Director. Among them, Zhong Yiqun has obtained the "Secretary of the Board of Directors Qualification Certificate for the STAR Market" issued by the Shanghai Stock Exchange and has passed the qualification filing of the Shanghai Stock Exchange, meeting the qualifications for the position of Secretary of the Board of Directors stipulated in the "Company Law" and the "STAR Market Stock Listing Rules of the Shanghai Stock Exchange."

Appointment of the Company's Securities Affairs Representative: The company's board of directors has agreed to appoint Lu Jiali as the company's securities affairs representative to assist the board secretary in daily operations. The term of office will commence from the date of approval by this board meeting until the expiration of the term of the third board of directors. Lu Jiali has obtained the "Sci-Tech Innovation Board Secretary Qualification Certificate" issued by the Shanghai Stock Exchange, and her qualifications comply with the relevant laws and regulations, including the "Company Law" and the "Shanghai Stock Exchange Sci-Tech Innovation Board Listing Rules."

The company's third-quarter report for 2021 shows that the net profit attributable to shareholders of the listed company in the third quarter of 2021 was 38,391,924.38 yuan, representing a year-on-year increase of 20.07%.

Digbei Network's data shows that VISHEE is committed to providing safe and effective rehabilitation products and comprehensive solutions for medical and professional institutions in niche areas such as pelvic floor and postpartum rehabilitation, neurological rehabilitation, and psychiatric rehabilitation. Currently, the company’s main products include rehabilitation medical devices and products such as electrical stimulation devices, magnetic stimulation devices, electrophysiological equipment, consumables, and accessories.